These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs. Krumpl G; Winkler M; Schneider W; Raberger G Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644 [TBL] [Abstract][Full Text] [Related]
3. A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs. Furukawa Y; Takayama S; Sawaki S; Inoue Y; Chiba S J Pharmacol Exp Ther; 1993 May; 265(2):801-6. PubMed ID: 8496825 [TBL] [Abstract][Full Text] [Related]
4. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent. O'Brien P; Drage D; Saeian K; Brooks HL; Warltier DC Am Heart J; 1992 Mar; 123(3):566-74. PubMed ID: 1539507 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent". Kobinger W; Lillie C Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920 [TBL] [Abstract][Full Text] [Related]
6. Effect of a bradycardic agent on the isolated blood-perfused canine heart. Schipke JD; Harasawa Y; Sugiura S; Alexander J; Burkhoff D Cardiovasc Drugs Ther; 1991 Apr; 5(2):481-8. PubMed ID: 1854656 [TBL] [Abstract][Full Text] [Related]
7. Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs. Raberger G; Krumpl G; Schneider W Int J Cardiol; 1987 Mar; 14(3):343-54. PubMed ID: 3557712 [TBL] [Abstract][Full Text] [Related]
8. Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria. Lillie C; Kobinger W J Cardiovasc Pharmacol; 1986; 8(4):791-7. PubMed ID: 2427820 [TBL] [Abstract][Full Text] [Related]
9. Influence of the force-frequency relation on left ventricular function during exercise in conscious dogs. Miura T; Miyazaki S; Guth BD; Kambayashi M; Ross J Circulation; 1992 Aug; 86(2):563-71. PubMed ID: 1638722 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function. Gout B; Jean J; Bril A J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735 [TBL] [Abstract][Full Text] [Related]
11. The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion. van Woerkens LJ; van der Giessen WJ; Verdouw PD Cardiovasc Drugs Ther; 1992 Feb; 6(1):59-65. PubMed ID: 1576097 [TBL] [Abstract][Full Text] [Related]
12. Heart rate and force-frequency effects on diastolic function of the left ventricle in exercising dogs. Miura T; Miyazaki S; Guth BD; Indolfi C; Ross J Circulation; 1994 May; 89(5):2361-8. PubMed ID: 8181162 [TBL] [Abstract][Full Text] [Related]
13. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. Schulz R; Rose J; Skyschally A; Heusch G J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647 [TBL] [Abstract][Full Text] [Related]
14. Effects of preload, afterload and inotropy on dynamics of ischemic segmental wall motion. Perlini S; Meyer TE; Foëx P J Am Coll Cardiol; 1997 Mar; 29(4):846-55. PubMed ID: 9091533 [TBL] [Abstract][Full Text] [Related]
15. Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs. Riley DC; Gross GJ; Kampine JP; Warltier DC Anesthesiology; 1987 Nov; 67(5):707-16. PubMed ID: 3674471 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the force-frequency effect on myocardial contractility by adrenergic stimulation in conscious dogs. Kambayashi M; Miura T; Oh BH; Rockman HA; Murata K; Ross J Circulation; 1992 Aug; 86(2):572-80. PubMed ID: 1353420 [TBL] [Abstract][Full Text] [Related]
17. Effect of zatebradine on contractility, relaxation and coronary blood flow. Breall JA; Watanabe J; Grossman W J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013 [TBL] [Abstract][Full Text] [Related]
18. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. Harkin CP; Pagel PS; Tessmer JP; Warltier DC J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041 [TBL] [Abstract][Full Text] [Related]
19. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals. De Pauw M; Vilaine JP; Heyndrickx GR Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245 [TBL] [Abstract][Full Text] [Related]
20. Effects of Zeneca ZD7288 in comparison with alinidine and UL-FS 49 on guinea pig sinoatrial node and ventricular action potentials. Briggs I; BoSmith RE; Heapy CG J Cardiovasc Pharmacol; 1994 Sep; 24(3):380-7. PubMed ID: 7528293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]